Zydus Wellness Ltd (ZYDUSWELL) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Zydus Wellness reported consolidated net sales growth of 12.7% and volume growth of 4.8% year-on-year.
- The acquisition of Naturell (India) Private Limited contributed to the results, adding a low single-digit share to the top line and operating at breakeven EBITDA.
- Personal Care segment achieved double-digit growth of 50.3% driven by strong consumer demand.
- Food & Nutrition segment recorded 8.8% growth.
- Gross margin showed a slight upward trend sequentially and year-on-year due to hedging strategies, favorable product mix, and price adjustments.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.